Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncology Institute, Inc. | Chief Medical Officer | Common Stock | 104K | $221K | $2.12 | May 21, 2024 | Direct |
Oncology Institute, Inc. | Chief Medical Officer | Non-Qualified Stock Option (right to buy) | 43.8K | May 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TOI | Oncology Institute, Inc. | May 21, 2024 | 2 | $0 | 4 | May 23, 2024 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Nov 21, 2023 | 1 | -$3.36K | 4 | Nov 22, 2023 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Nov 14, 2023 | 2 | -$5K | 4 | Nov 16, 2023 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Mar 17, 2023 | 2 | $0 | 4 | Mar 21, 2023 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Nov 17, 2022 | 2 | $0 | 4 | Nov 21, 2022 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Nov 15, 2022 | 1 | -$404 | 4/A | Nov 22, 2022 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Mar 21, 2022 | 2 | $0 | 4/A | Mar 29, 2022 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Nov 12, 2021 | 4 | $0 | 4 | Nov 16, 2021 | Chief Medical Officer |
TOI | Oncology Institute, Inc. | Nov 12, 2021 | 0 | $0 | 3 | Nov 16, 2021 | Chief Medical Officer |